Autonomix Medical, Inc. AMIX

Full chart Compare
Set alert

Price alert · AMIX

All alert types
1.67 USD -0.01 (-0.89%)

Nov 3, 2026, 3:59 PM EST

1.63 Day range 1.71
1.63 52-week range 32.55
YTD
-85.58%
1 year
-92.15%
Market cap
3.27M
EPS (ttm)
-39.67
Shares out
1.77M
Forward P/E
-0.46
YTD return
-85.58%
1-year return
-92.15%
Volume
36.46K
Avg volume
3.02M
Open
1.68
Previous close
1.68
Day's range
1.63 – 1.71
52-week range
1.63 – 32.55
Price target
28.00 (+1581.7%)

1m +0.02 (+1.19%)

1.681.691.70Nov 31.70

Key statistics

Enterprise value
78.74K
PEG ratio
0.00
Price / sales
0.00
Price / book
1.06
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-5.49M
Total cash
5.16M
Total debt
1.09M
Return on equity
-27017.08%
Short % of float
2.85%
50-day average
8.29
200-day average
26.81

Financials — quick view

All financials
AMIX Revenue — quarterly 0
2023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
AMIX Net income — quarterly -2.73M
2023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
AMIX EPS — quarterly -5.02
2023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Upgrades / downgrades

AMIX analyst upgrades and downgrades
DateFirmActionFromTo
Sep 3, 2024Ladenburg Thalmanninit—Buy

About Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on AMIX — it syncs with the Stock Master app.

Institution ownership

AMIX institution ownership
Holder% heldSharesValueReported
Mariner, LLC0.49%5,61919.05KSep 29, 2024
Geode Capital Management, LLC0.39%4,48115.19KSep 29, 2024
HRT Financial LP0.26%3,05310.35KSep 29, 2024
PNC Financial Services Group, Inc.0.16%1,8376.23KSep 29, 2024
Two Sigma Securities, LLC0.10%1,1844.01KSep 29, 2024
Virtu Financial LLC0.07%7562.56KSep 29, 2024

Fund ownership

AMIX fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.29%3,29611.17KOct 30, 2024
iShares Micro Cap ETF0.14%1,5895.39KOct 30, 2024
Fidelity Total Market Index Fund0.09%1,0353.51KOct 30, 2024
Fidelity Series Total Market Index Fund0.07%7762.63KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.03%3471.18KOct 30, 2024
EQ Advisors Trust-1290 VT Micro Cap Port0.01%160542Sep 29, 2024